These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24771538)

  • 21. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
    Feneberg E; Steinacker P; Volk AE; Weishaupt JH; Wollmer MA; Boxer A; Tumani H; Ludolph AC; Otto M
    J Neural Transm (Vienna); 2016 Mar; 123(3):289-96. PubMed ID: 26659729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice.
    Götzl JK; Colombo AV; Fellerer K; Reifschneider A; Werner G; Tahirovic S; Haass C; Capell A
    Mol Neurodegener; 2018 Sep; 13(1):48. PubMed ID: 30180904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
    Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
    Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid.
    Willemse EA; Durieux-Lu S; van der Flier WM; Pijnenburg YA; de Jonge R; Teunissen CE
    J Alzheimers Dis; 2016 Apr; 53(1):107-16. PubMed ID: 27104901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
    Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
    Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis.
    Xu HM; Tan L; Wan Y; Tan MS; Zhang W; Zheng ZJ; Kong LL; Wang ZX; Jiang T; Tan L; Yu JT
    Mol Neurobiol; 2017 Mar; 54(2):1187-1195. PubMed ID: 26820675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.
    Fenoglio C; Galimberti D; Cortini F; Kauwe JS; Cruchaga C; Venturelli E; Villa C; Serpente M; Scalabrini D; Mayo K; Piccio LM; Clerici F; Albani D; Mariani C; Forloni G; Bresolin N; Goate AM; Scarpini E
    J Alzheimers Dis; 2009; 18(3):603-12. PubMed ID: 19625741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the variant Cys139Arg at GRN gene to the clinical spectrum of frontotemporal lobar degeneration.
    Piaceri I; Pradella S; Cupidi C; Nannucci S; Polito C; Bagnoli S; Tedde A; Smirne N; Anfossi M; Gallo M; Bernardi L; Colao R; Maletta R; Bruni AC; Sorbi S; Nacmias B
    J Alzheimers Dis; 2014; 40(3):679-85. PubMed ID: 24503614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin.
    Hu F; Padukkavidana T; Vægter CB; Brady OA; Zheng Y; Mackenzie IR; Feldman HH; Nykjaer A; Strittmatter SM
    Neuron; 2010 Nov; 68(4):654-67. PubMed ID: 21092856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced serum progranulin level might be associated with Parkinson's disease risk.
    Mateo I; González-Aramburu I; Pozueta A; Vázquez-Higuera JL; Rodríguez-Rodríguez E; Sánchez-Juan P; Calero M; Dobato JL; Infante J; Berciano J; Combarros O
    Eur J Neurol; 2013 Dec; 20(12):1571-3. PubMed ID: 23398167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progranulin and Amyloid-β Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease.
    Körtvélyessy P; Gukasjan A; Sweeney-Reed CM; Heinze HJ; Thurner L; Bittner DM
    J Alzheimers Dis; 2015; 46(2):375-80. PubMed ID: 25777512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival.
    Van Damme P; Van Hoecke A; Lambrechts D; Vanacker P; Bogaert E; van Swieten J; Carmeliet P; Van Den Bosch L; Robberecht W
    J Cell Biol; 2008 Apr; 181(1):37-41. PubMed ID: 18378771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.
    Galimberti D; Dell'Osso B; Fenoglio C; Villa C; Cortini F; Serpente M; Kittel-Schneider S; Weigl J; Neuner M; Volkert J; Leonhard C; Olmes DG; Kopf J; Cantoni C; Ridolfi E; Palazzo C; Ghezzi L; Bresolin N; Altamura AC; Scarpini E; Reif A
    PLoS One; 2012; 7(4):e32164. PubMed ID: 22505994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.
    Galimberti D; Fumagalli GG; Fenoglio C; Cioffi SMG; Arighi A; Serpente M; Borroni B; Padovani A; Tagliavini F; Masellis M; Tartaglia MC; van Swieten J; Meeter L; Graff C; de Mendonça A; Bocchetta M; Rohrer JD; Scarpini E;
    Neurobiol Aging; 2018 Feb; 62():245.e9-245.e12. PubMed ID: 29146050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progranulin gene variation affects serum progranulin levels differently in Danish bipolar individuals compared with healthy controls.
    Buttenschøn HN; Nielsen MN; Thotakura G; Lee CW; Nykjær A; Mors O; Glerup S
    Psychiatr Genet; 2017 Jun; 27(3):89-95. PubMed ID: 28225367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progranulin: an emerging target for FTLD therapies.
    Gass J; Prudencio M; Stetler C; Petrucelli L
    Brain Res; 2012 Jun; 1462():118-28. PubMed ID: 22338605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
    Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
    Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.
    Tanaka A; Tsukamoto H; Mitoma H; Kiyohara C; Ueda N; Ayano M; Ohta S; Inoue Y; Arinobu Y; Niiro H; Horiuchi T; Akashi K
    Arthritis Res Ther; 2012 Nov; 14(6):R244. PubMed ID: 23140401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The
    Xu W; Han SD; Zhang C; Li JQ; Wang YJ; Tan CC; Li HQ; Dong Q; Mei C; Tan L; Yu JT
    Sci Adv; 2020 Oct; 6(43):. PubMed ID: 33087363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel progranulin variants do not disrupt progranulin secretion and cleavage.
    Karch CM; Jeng AT; Skorupa T; Cruchaga C; Goate AM
    Neurobiol Aging; 2013 Nov; 34(11):2538-40. PubMed ID: 23759146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.